Genetic Variations and mRNA Expression of NRF2 in Parkinson’s Disease
Nuclear factor erythroid 2-like 2 (NRF2) encodes a transcription factor regulating mechanisms of cellular protection and is activated by oxidative stress. NRF2 has therefore been hypothesized to confer protection against Parkinson’s disease and so far an NRF2 haplotype has been reported to decrease...
Main Authors: | Caroline Ran, Karin Wirdefeldt, Lovisa Brodin, Mehrafarin Ramezani, Marie Westerlund, Fengqing Xiang, Anna Anvret, Thomas Willows, Olof Sydow, Anders Johansson, Dagmar Galter, Per Svenningsson, Andrea Carmine Belin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2017/4020198 |
Similar Items
-
Possible Involvement of a Mitochondrial Translation Initiation Factor 3 Variant Causing Decreased mRNA Levels in Parkinson's Disease
by: Anna Anvret, et al.
Published: (2010-01-01) -
ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia
by: Dagmar Galter, et al.
Published: (2003-12-01) -
Synaptic proteins in CSF relate to Parkinson’s disease stage markers
by: Erika Bereczki, et al.
Published: (2017-02-01) -
S100B polymorphisms are associated with age of onset of Parkinson’s disease
by: Camilla Fardell, et al.
Published: (2018-03-01) -
NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs
by: Mari Hämäläinen, et al.
Published: (2019-01-01)